CD163 and cervical cancer: Nevertheless, Carus et al. recently assessed tumor-associated CD66b(+) neutrophils and CD163(+) macrophages by immunohistochemistry in whole tissue sections of 101 FIGO IB and IIA cervical cancer patients and found tumor-associated neutrophil count was an independent prognostic factor for short recurrence free survival in localised cervical cancer [14].